Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES‐10 cells) highly expressing vascular endothelial growth factor and its receptor
Emiko Nakataki(Tokushima University), Saburo Sone(Io Therapeutics (United States)), Hiroaki Muguruma(Tokushima University), Hisanori Uehara(Tokushima University Hospital), Katsumi Kito(Ehime University), Seiji Yano(Kanazawa University Hospital), Yuka Matsumori, Akihito Yokoyama(Hiroshima University), Hironobu Hamada, Soji Kakiuchi(Tokushima Prefectural Central Hospital), Hisatsugu Goto(Tokushima University), Yoshiyuki Bando(Tokushima University)
Cited by 44
Related Papers
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
|The Lancet Respiratory Medicine|2016|465
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
|Nature Communications|2019|360
CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis.
|American Journal of Roentgenology|1997|296